$28.28
-0.44-1.53%
At Close: -
$28.25
-0.03-0.09%
After Hours: 4:10 PM EDT
15 minutes delayed
Comments
Loading...
Marathon Oil
MRONYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Marathon Oil (NYSE:MRO) Stock, Analyst Ratings, Price Targets, Forecasts
Marathon Oil Corp has a consensus price target of $31.63 based on the ratings of 23 analysts. The high is $39 issued by Susquehanna on July 22, 2024. The low is $25 issued by Jefferies on May 15, 2023. The 3 most-recent analyst ratings were released by Susquehanna, JP Morgan, and Scotiabank on July 22, 2024, July 17, 2024, and July 12, 2024, respectively. With an average price target of $33.67 between Susquehanna, JP Morgan, and Scotiabank, there's an implied 19.15% upside for Marathon Oil Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Susquehanna
JP Morgan
Scotiabank
Mizuho
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Marathon Oil
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | 38.03% | Susquehanna | Biju Perincheril | $33 → $39 | Maintains | Positive | Get Alert |
| 07/17/2024 | Buy Now | 16.79% | JP Morgan | Arun Jayaram | → $33 | Downgrade | Overweight → Neutral | Get Alert |
| 07/12/2024 | Buy Now | 2.64% | Scotiabank | Paul Cheng | $45 → $29 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 06/05/2024 | Buy Now | 20.33% | Mizuho | Nitin Kumar | $33 → $34 | Maintains | Neutral | Get Alert |
| 05/31/2024 | Buy Now | 2.64% | Wells Fargo | Roger Read | $38 → $29 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/13/2024 | Buy Now | 16.79% | Mizuho | Nitin Kumar | $31 → $33 | Maintains | Neutral | Get Alert |
| 05/06/2024 | Buy Now | 23.87% | Truist Securities | Neal Dingmann | $36 → $35 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 13.25% | Benchmark | Subash Chandra | → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/23/2024 | Buy Now | 13.25% | Benchmark | Subash Chandra | → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/22/2024 | Buy Now | 16.79% | Susquehanna | Biju Perincheril | → $33 | Maintains | Positive | Get Alert |
| 04/19/2024 | Buy Now | 20.33% | Piper Sandler | Mark Lear | $32 → $34 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | -4.44% | Morgan Stanley | Devin McDermott | $26 → $27 | Maintains | Equal-Weight | Get Alert |
| 04/11/2024 | Buy Now | 59.26% | Scotiabank | Paul Cheng | $35 → $45 | Maintains | Sector Outperform | Get Alert |
| 04/10/2024 | Buy Now | 23.87% | Barclays | Betty Jiang | → $35 | Initiates | → Overweight | Get Alert |
| 04/05/2024 | Buy Now | 27.41% | Truist Securities | Neal Dingmann | $35 → $36 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | -7.98% | Morgan Stanley | Devin McDermott | $24 → $26 | Maintains | Equal-Weight | Get Alert |
| 03/26/2024 | Buy Now | 6.18% | Goldman Sachs | Neil Mehta | $26.5 → $30 | Maintains | Neutral | Get Alert |
| 03/22/2024 | Buy Now | 9.72% | Mizuho | Nitin Kumar | $28 → $31 | Maintains | Neutral | Get Alert |
| 03/22/2024 | Buy Now | 27.41% | Stifel | Derrick Whitfield | $39 → $36 | Maintains | Buy | Get Alert |
| 03/14/2024 | Buy Now | 9.72% | Argus Research | Bill Selesky | → $31 | Upgrade | Hold → Buy | Get Alert |
| 03/13/2024 | Buy Now | 13.25% | Benchmark | Subash Chandra | $25 → $32 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 27.41% | Wells Fargo | Roger Read | $32 → $36 | Maintains | Overweight | Get Alert |
| 03/06/2024 | Buy Now | -4.44% | UBS | Josh Silverstein | $28 → $27 | Maintains | Neutral | Get Alert |
| 03/05/2024 | Buy Now | 16.79% | RBC Capital | Scott Hanold | → $33 | Reiterates | Outperform → Outperform | Get Alert |
| 02/23/2024 | Buy Now | 23.87% | Truist Securities | Neal Dingmann | $38 → $35 | Maintains | Buy | Get Alert |
| 01/24/2024 | Buy Now | 13.25% | Raymond James | John Freeman | $35 → $32 | Maintains | Strong Buy | Get Alert |
| 01/24/2024 | Buy Now | 13.25% | Piper Sandler | Mark Lear | $34 → $32 | Maintains | Overweight | Get Alert |
| 01/12/2024 | Buy Now | -11.52% | Benchmark | Subash Chandra | $28 → $25 | Maintains | Buy | Get Alert |
| 12/15/2023 | Buy Now | 23.87% | Raymond James | John Freeman | $45 → $35 | Maintains | Strong Buy | Get Alert |
| 12/14/2023 | Buy Now | -0.9% | UBS | Josh Silverstein | $34 → $28 | Downgrade | Buy → Neutral | Get Alert |
| 12/11/2023 | Buy Now | -11.52% | Morgan Stanley | Devin McDermott | $27 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/20/2023 | Buy Now | 38.03% | Stifel | Derrick Whitfield | $40 → $39 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | 23.87% | Susquehanna | Biju Perincheril | $34 → $35 | Maintains | Positive | Get Alert |
| 10/18/2023 | Buy Now | 15.02% | Citigroup | Scott Gruber | $31 → $32.5 | Maintains | Buy | Get Alert |
| 10/18/2023 | Buy Now | 20.33% | Susquehanna | Biju Perincheril | $30 → $34 | Maintains | Positive | Get Alert |
| 10/12/2023 | Buy Now | -0.9% | Benchmark | Subash Chandra | $32 → $28 | Maintains | Buy | Get Alert |
| 10/04/2023 | Buy Now | 30.95% | UBS | Josh Silverstein | $35 → $37 | Maintains | Buy | Get Alert |
| 10/02/2023 | Buy Now | -4.44% | Morgan Stanley | Devin McDermott | $26 → $27 | Maintains | Overweight | Get Alert |
| 09/20/2023 | Buy Now | 9.72% | Citigroup | Scott Gruber | $29 → $31 | Maintains | Buy | Get Alert |
| 09/18/2023 | Buy Now | 9.72% | Mizuho | Nitin Kumar | $30 → $31 | Maintains | Neutral | Get Alert |
| 09/14/2023 | Buy Now | 59.26% | Raymond James | John Freeman | $40 → $45 | Maintains | Strong Buy | Get Alert |
| 08/17/2023 | Buy Now | 23.87% | UBS | Josh Silverstein | $29 → $35 | Maintains | Buy | Get Alert |
| 08/16/2023 | Buy Now | 6.18% | Mizuho | Nitin Kumar | $28 → $30 | Maintains | Neutral | Get Alert |
| 08/14/2023 | Buy Now | 20.33% | Piper Sandler | Mark Lear | $32 → $34 | Maintains | Overweight | Get Alert |
| 08/11/2023 | Buy Now | 38.03% | Stifel | Derrick Whitfield | $38 → $39 | Maintains | Buy | Get Alert |
| 07/24/2023 | Buy Now | 41.57% | Raymond James | John Freeman | $48 → $40 | Maintains | Strong Buy | Get Alert |
| 07/21/2023 | Buy Now | 6.18% | Susquehanna | Biju Perincheril | $32 → $30 | Maintains | Positive | Get Alert |
| 07/18/2023 | Buy Now | -7.98% | Morgan Stanley | Devin McDermott | $27 → $26 | Maintains | Overweight | Get Alert |
| 07/18/2023 | Buy Now | 23.87% | Wells Fargo | Roger Read | $37 → $35 | Maintains | Overweight | Get Alert |
| 07/14/2023 | Buy Now | -0.9% | Benchmark | Subash Chandra | $32 → $28 | Maintains | Buy | Get Alert |
| 07/13/2023 | Buy Now | 16.79% | RBC Capital | Scott Hanold | $35 → $33 | Maintains | Outperform | Get Alert |
| 07/13/2023 | Buy Now | 2.64% | Citigroup | Scott Gruber | $27 → $29 | Maintains | Buy | Get Alert |
| 07/12/2023 | Buy Now | -11.52% | Goldman Sachs | Neil Mehta | → $25 | Upgrade | Sell → Neutral | Get Alert |
| 06/13/2023 | Buy Now | 13.25% | Piper Sandler | Mark Lear | $35 → $32 | Maintains | Overweight | Get Alert |
| 05/19/2023 | Buy Now | -0.9% | Mizuho | Nitin Kumar | $31 → $28 | Maintains | Neutral | Get Alert |
| 05/15/2023 | Buy Now | -11.52% | Jefferies | Lloyd Byrne | $29 → $25 | Maintains | Hold | Get Alert |
| 05/08/2023 | Buy Now | 30.95% | Wells Fargo | Roger Read | $38 → $37 | Maintains | Overweight | Get Alert |
| 04/21/2023 | Buy Now | 13.25% | Susquehanna | Biju Perincheril | $35 → $32 | Maintains | Positive | Get Alert |
| 04/21/2023 | Buy Now | -0.9% | Goldman Sachs | Neil Mehta | $24 → $28 | Maintains | Sell | Get Alert |
| 04/21/2023 | Buy Now | 69.88% | Raymond James | John Freeman | $43 → $48 | Maintains | Strong Buy | Get Alert |
| 04/19/2023 | Buy Now | 38.03% | Piper Sandler | Mark Lear | $40 → $39 | Maintains | Overweight | Get Alert |
| 04/19/2023 | Buy Now | 16.79% | UBS | Josh Silverstein | → $33 | Assumes | → Buy | Get Alert |
| 04/18/2023 | Buy Now | 13.25% | Benchmark | Subash Chandra | → $32 | Reiterates | → Buy | Get Alert |
| 04/18/2023 | Buy Now | 34.49% | Wells Fargo | Roger Read | $40 → $38 | Maintains | Overweight | Get Alert |
| 03/30/2023 | Buy Now | 30.95% | Stifel | Derrick Whitfield | $38 → $37 | Maintains | Buy | Get Alert |
| 03/27/2023 | Buy Now | -4.44% | Morgan Stanley | Devin McDermott | $28 → $27 | Maintains | Overweight | Get Alert |
| 03/27/2023 | Buy Now | 52.19% | Raymond James | John Freeman | $48 → $43 | Maintains | Strong Buy | Get Alert |
| 03/24/2023 | Buy Now | -15.06% | Goldman Sachs | Neil Mehta | $29 → $24 | Maintains | Sell | Get Alert |
| 03/23/2023 | Buy Now | -4.44% | Citigroup | Scott Gruber | → $27 | Upgrade | Neutral → Buy | Get Alert |
| 02/23/2023 | Buy Now | -4.44% | Citigroup | Scott Gruber | $30 → $27 | Maintains | Neutral | Get Alert |
| 02/21/2023 | Buy Now | 41.57% | Wells Fargo | Roger Read | $41 → $40 | Maintains | Overweight | Get Alert |
| 02/16/2023 | Buy Now | 13.25% | Benchmark | Subash Chandra | → $32 | Upgrade | Hold → Buy | Get Alert |
| 01/25/2023 | Buy Now | 45.11% | Wells Fargo | Roger Read | → $41 | Initiates | → Overweight | Get Alert |
| 01/24/2023 | Buy Now | -0.9% | Morgan Stanley | Devin McDermott | $27 → $28 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/13/2023 | Buy Now | 6.18% | Citigroup | Scott Gruber | $31 → $30 | Maintains | Neutral | Get Alert |
| 01/13/2023 | Buy Now | 41.57% | Piper Sandler | Mark Lear | $42 → $40 | Maintains | Overweight | Get Alert |
| 01/10/2023 | Buy Now | 13.25% | Mizuho | Nitin Kumar | → $32 | Downgrade | Buy → Neutral | Get Alert |
| 12/07/2022 | Buy Now | 23.87% | Barclays | Jeanine Wai | $34 → $35 | Maintains | Overweight | Get Alert |
| 11/28/2022 | Buy Now | 69.88% | Raymond James | John Freeman | $37 → $48 | Maintains | Strong Buy | Get Alert |
| 11/23/2022 | Buy Now | 6.18% | Goldman Sachs | Brian Singer | $27 → $30 | Maintains | Sell | Get Alert |
| 11/17/2022 | Buy Now | 48.65% | Piper Sandler | Mark Lear | $38 → $42 | Maintains | Overweight | Get Alert |
| 11/07/2022 | Buy Now | 34.49% | RBC Capital | Scott Hanold | $35 → $38 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | 13.25% | Credit Suisse | William Janela | $30 → $32 | Maintains | Neutral | Get Alert |
| 10/24/2022 | Buy Now | 30.95% | Raymond James | John Freeman | $35 → $37 | Maintains | Strong Buy | Get Alert |
| 10/19/2022 | Buy Now | -4.44% | Morgan Stanley | Devin McDermott | $28 → $27 | Maintains | Equal-Weight | Get Alert |
| 10/19/2022 | Buy Now | 20.33% | Barclays | Jeanine Wai | $31 → $34 | Maintains | Overweight | Get Alert |
| 10/19/2022 | Buy Now | 6.18% | Jefferies | Lloyd Byrne | → $30 | Initiates | → Hold | Get Alert |
| 10/18/2022 | Buy Now | 34.49% | Piper Sandler | Mark Lear | $36 → $38 | Maintains | Overweight | Get Alert |
| 09/21/2022 | Buy Now | -4.44% | Citigroup | Scott Gruber | $24 → $27 | Maintains | Neutral | Get Alert |
| 08/31/2022 | Buy Now | 9.72% | Barclays | Jeanine Wai | $35 → $31 | Maintains | Overweight | Get Alert |
| 08/29/2022 | Buy Now | -0.9% | Morgan Stanley | Devin McDermott | $31 → $28 | Maintains | Equal-Weight | Get Alert |
| 08/18/2022 | Buy Now | 13.25% | Mizuho | Vincent Lovaglio | $34 → $32 | Maintains | Buy | Get Alert |
| 07/26/2022 | Buy Now | 23.87% | Barclays | Jeanine Wai | $37 → $35 | Maintains | Overweight | Get Alert |
| 07/26/2022 | Buy Now | 23.87% | Raymond James | John Freeman | $40 → $35 | Maintains | Strong Buy | Get Alert |
| 07/22/2022 | Buy Now | 45.11% | Piper Sandler | Mark Lear | $38 → $41 | Maintains | Overweight | Get Alert |
| 07/19/2022 | Buy Now | 9.72% | Morgan Stanley | Devin McDermott | $33 → $31 | Maintains | Equal-Weight | Get Alert |
| 07/19/2022 | Buy Now | -11.52% | B of A Securities | Doug Leggate | $28 → $25 | Maintains | Underperform | Get Alert |
| 07/19/2022 | Buy Now | 20.33% | Mizuho | Vincent Lovaglio | $38 → $34 | Maintains | Buy | Get Alert |
| 07/14/2022 | Buy Now | 34.49% | Piper Sandler | Mark Lear | $39 → $38 | Maintains | Overweight | Get Alert |
| 07/05/2022 | Buy Now | -11.52% | Goldman Sachs | Brian Singer | $29 → $25 | Maintains | Sell | Get Alert |
FAQ
What is the target price for Marathon Oil (MRO) stock?
The latest price target for Marathon Oil (NYSE:MRO) was reported by Susquehanna on July 22, 2024. The analyst firm set a price target for $39.00 expecting MRO to rise to within 12 months (a possible 38.03% upside). 46 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Marathon Oil (MRO)?
The latest analyst rating for Marathon Oil (NYSE:MRO) was provided by Susquehanna, and Marathon Oil maintained their positive rating.
When was the last upgrade for Marathon Oil (MRO)?
The last upgrade for Marathon Oil Corp happened on March 14, 2024 when Argus Research raised their price target to $31. Argus Research previously had a hold for Marathon Oil Corp.
When was the last downgrade for Marathon Oil (MRO)?
The last downgrade for Marathon Oil Corp happened on July 17, 2024 when JP Morgan changed their price target from N/A to $33 for Marathon Oil Corp.
When is the next analyst rating going to be posted or updated for Marathon Oil (MRO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marathon Oil, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marathon Oil was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Marathon Oil (MRO) correct?
While ratings are subjective and will change, the latest Marathon Oil (MRO) rating was a maintained with a price target of $33.00 to $39.00. The current price Marathon Oil (MRO) is trading at is $28.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.